XBIOTECH INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $755.6M | $714.6M |
| FY2020 | — | $348.6M | $237.4M |
| FY2021 | — | $269.4M | $237.0M |
| FY2022 | — | $240.4M | $157.3M |
| FY2023 | — | $218.8M | $200.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $755.6M | $714.6M |
| FY2020 | — | $348.6M | $237.4M |
| FY2021 | — | $269.4M | $237.0M |
| FY2022 | — | $240.4M | $157.3M |
| FY2023 | — | $218.8M | $200.0M |